英文别名 |
((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid;PMEA;9-[2-phosphonylmethoxyethyl]adenine;2-(6-amino-9h-purin-9-yl)ethoxy]methylphosphonic acid;((2-(6-amino-9h-purin-9-yl)ethoxy)methyl)-phosphonic aci;9-(2-phosphonylmethoxyethyl)adenine;((2-(6-Amino-9H-purin-9-yl)ethoxy)-methyl)phosphonic acid;Adefovir;Adefovir Dipivoxil;gs0393;GS-393;P-[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic acid, 9-(2-phosphonylmethoxyethyl)adenine;Adefovi;A Duff Vee;Adefovir API;Adefovir(PMEA);GS 0393;Adefovir98%;adefovir ,97%;GS 393;9-(2-(Phosphonomethoxy)ethyl)adenine;N-(2-Phosphonylmethoxyethyl)adenine;C8H12N5O4P;9-[2-(phosphonomethoxy)ethyl]adenine;2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid;{[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid;N-(2-Phophonomethoxyethyl-2,6-diaminopurine);Phosphonic acid, [[2-(6-amino;adefovir(1-);9-(2-phosphonomethoxyethyl)adenine;Adefovir (USAN/INN);[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic Acid;(2-(6-amino-9H-purin-9-yl)ethoxy)methylphosphonic acid;9-[(2-phosphonylmethoxy)ethyl]adenine;ADEFOVIR [MART.];AC-012;ADEFOVIR [MI];9-(2-Phosphorylmethoxyethyl)adenine;SR-01000945034;NS00001232;Phosphonylmethoxyethyl-a;J05AF08;BA166179;NCGC00160539-02;P-[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-phosphonic acid;9-[3-(Phosphonomethoxy)ethyl]adenine (PMEA);ADEFOVIR [INN];Z1741977297;Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-;P-[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic acid;FT-0601785;9-[2-phosphonomethoxyethyl]adenine;PMEA, GS-393, 9-(2-Phosphonylmethoxyethyl)adenine;BCP22955;CHEMBL484;D02768;SCHEMBL49373;UNII-6GQP90I798;CHEBI:134512;106941-25-7;SUPKOOSCJHTBAH-UHFFFAOYSA-N;DTXSID6046214;Q-200594;CAS-106941-25-7;ADEFOVIR [VANDF];BRN 3561094;EN300-6733813;[2-(6-Amino-purin-9-yl)-ethoxymethyl]-phosphonic acid(PMEA);hydrogen {[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}phosphonate;(PMEA)[2-(6-Amino-purin-9-yl)-ethoxymethyl]-phosphonic acid;Phosphonic acid, ((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)-;((2-6-amino-9H-purin-9-yl) ethoxy) methyl)- phosphonic acid.;Adefovir, >=98% (HPLC);Q353551;HY-B1826;KS-5018;HSDB 8079;SY015278;NCGC00160539-01;Phosphonic acid, ((2-6-amino-9H-purin-9-YL)ethoxy)methyl;AMD3100 and PMEA;ADEFOVIR [USAN];SR-01000945034-1;5HG;DB13868;GS-0393;ADEFOVIR (MART.);Tox21_111882;CHEBI:2469;[2-(6-amino-9H-purin-9-yl)ethoxy]methylphosphonic acid;Adefovir [USAN:INN:BAN];ADEFOVIR [WHO-DD];106941-25-7 (free acid);DRG-0156;DTXCID4026214;6GQP90I798;MFCD00866943;[2-(6-Amino-purin-9-yl)-ethoxymethyl]-phosphonic acid;9-PMEA;Adefovirum;BDBM50001103;s5068;AKOS005259246;CS-0013877;A801540;BRD-K77484724-001-02-0;BRD-K77484724-001-03-8;Adefovir; P-[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic acid; 9-(2-phosphonylmethoxyethyl)adenine; PMEA; GS-393 |